User profiles for Laurent Chouchana
Laurent Chouchana, PharmD, PhDCentre Régional de Pharmacovigilance, Hopital Cochin, AP-HP Verified email at aphp.fr Cited by 1131 |
Risk of scleroderma according to the type of immune checkpoint inhibitors
…, M Wislez, L Mouthon, L Chouchana - Autoimmunity …, 2020 - Elsevier
Introduction Immune checkpoint inhibitors (ICIs) are associated with immune-related
adverse events (irAEs). Among them, ICIs-induced systemic sclerosis (SSc) is poorly known. …
adverse events (irAEs). Among them, ICIs-induced systemic sclerosis (SSc) is poorly known. …
Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach
Objectives IgA vasculitis (IgAV) is an immune complex small-vessel vasculitis. Drug-induced
IgAV cases were rarely reported in the literature. Drug causality assessment is challenging …
IgAV cases were rarely reported in the literature. Drug causality assessment is challenging …
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French …
…, D Viard, N Parassol, A Granvuillemin, L Chouchana… - Therapies, 2020 - Elsevier
Introduction COVID-19 is an unprecedented challenge for physicians and scientists.
Several publicized drugs are being used with not much evidence of their efficacy such as …
Several publicized drugs are being used with not much evidence of their efficacy such as …
[HTML][HTML] Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
…, D Carrié, G Durrieu, A Sommet, L Chouchana… - Clinical Microbiology …, 2021 - Elsevier
Objectives In recent clinical trials some cardiac arrhythmias were reported with use of
remdesivir for COVID-19. To address this safety concern, we investigated whether use of …
remdesivir for COVID-19. To address this safety concern, we investigated whether use of …
[HTML][HTML] Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency
…, N Pallet, V Boige, J Ciccolini, L Chouchana… - European Journal of …, 2023 - Elsevier
Fluoropyrimidine drugs (FP) are the backbone of many chemotherapy protocols for treating
solid tumours. The rate-limiting step of fluoropyrimidine catabolism is dihydropyrimidine …
solid tumours. The rate-limiting step of fluoropyrimidine catabolism is dihydropyrimidine …
Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study
…, JM Treluyer, B Terrier, L Chouchana - …, 2022 - academic.oup.com
DEAR EDITOR, COVID-19 vaccines rely on next-generation vaccine platforms of which safety
profiles are, to date, not well characterized. Sporadic cases of GCA secondary to COVID-…
profiles are, to date, not well characterized. Sporadic cases of GCA secondary to COVID-…
Features of inflammatory heart reactions following mRNA COVID‐19 vaccination at a global level
L Chouchana, A Blet, M Al‐Khalaf… - Clinical …, 2022 - Wiley Online Library
Myocarditis and pericarditis may constitute adverse reactions of mRNA coronavirus disease
2019 (COVID‐19) vaccines. This study aimed to document these reactions and to assess …
2019 (COVID‐19) vaccines. This study aimed to document these reactions and to assess …
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and …
…, TSTD Monitoring, S Benaboud, L Chouchana… - Therapies, 2022 - Elsevier
Objectives Nirmatrelvir in association with ritonavir (PAXLOVID™, Pfizer) is an antiviral agent
targeting the 3-chymotrypsin–like cysteine protease enzyme (3C-like protease or Mpro) …
targeting the 3-chymotrypsin–like cysteine protease enzyme (3C-like protease or Mpro) …
Intravenous ketamine and progressive cholangiopathy in COVID-19 patients
…, N Pons-Kerjean, A Vallet-Pichard, L Chouchana… - Journal of …, 2021 - Elsevier
Discussion The characteristics of liver injury observed in this series were consistent with all
previous descriptions of ketamine cholangiopathies, including dilatations and strictures of the …
previous descriptions of ketamine cholangiopathies, including dilatations and strictures of the …
Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273)
…, JM Treluyer, C Charlier, L Chouchana - British Journal of …, 2022 - Wiley Online Library
Several cases of herpes zoster (HZ) following mRNA COVID‐19 vaccination (BNT162b2
and mRNA‐1273) have been reported, and the first epidemiological evidence suggests an …
and mRNA‐1273) have been reported, and the first epidemiological evidence suggests an …